CXCL12 and cancer: SDF-1 activates Akt and ERK pathways, promoting invasion, metastasis, cell cycle progression, epithelial-mesenchymal transition, proliferation, and migration in various cancer types, including lung cancer, AML and glioblastoma (18, 19).